SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882104-20-000043
Filing Date
2020-04-07
Accepted
2020-04-07 08:46:09
Documents
2
Period of Report
2020-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158626355151598.html 4  
1 FORM 4 wf-form4_158626355151598.xml 4 3077
2 POWER OF ATTORNEY /S/ NATHAN KRYSZAK, ATTORNEY-IN-FACT FOR EDWARD IMBROGNO ex-24.htm EX-24 3642
  Complete submission text file 0000882104-20-000043.txt   8165
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451
Business Address
Imbrogno Edward (Reporting) CIK: 0001780493 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 20778499